Eczema

WILMINGTON, Del., July 29, 2026 Incyte announced that the European Commission (EC) has approved Opzelura® (ruxolitinib) cream for the...

BOSTON, July 27, 2026 Bambusa Therapeutics announced encouraging preliminary proof-of-concept results from its ongoing global Phase 1 clinical trial...

JERSEY CITY, N.J., July 24, 2026 Organon (NYSE: OGN) presented new post hoc pooled Phase 3 data from the...

WESTLAKE VILLAGE, Calif., July 8, 2026 Arcutis Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted...